Cadila group receives USFDA approval for Ranolazine Extended-Release
Zydus Cadila has received final USFDA approval to market generic Ranolazine Extended-Release tablets used for treatment of chronic angina in US markets. The company will […]
Zydus Cadila has received final USFDA approval to market generic Ranolazine Extended-Release tablets used for treatment of chronic angina in US markets. The company will […]
Unichem Laboratories has received USFDA approval to market Chlorthalidone tablets in USA. The prescribed drug is used to treat high blood pressure. It will be […]
Granules India has received USFDA approval for a generic central nervous system stimulant drug- Amphetamine Sulfate tablets. The prescribed drug will be produced in strengths […]
Copyright © 2024 | WordPress Theme by MH Themes